N-Decylimidazole → Cupric acetate

반응식

[CH2:1]([N:11]1[CH:15]=[CH:14][N:13]=[CH:12]1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH3:10].O.[C:17]([O-:20])(=[O:19])[CH3:18].[Cu+2:21].[C:22]([O-:25])(=[O:24])[CH3:23]>>[CH2:1]([N:11]1[CH:15]=[CH:14][N:13]=[CH:12]1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH3:10].[C:17]([O-:20])(=[O:19])[CH3:18].[Cu+2:21].[C:22]([O-:25])(=[O:24])[CH3:23]

참가 물질

반응물 2

HCID 93164N-Decylimidazole

HCID 165397Cupric acetate monohydrate

생성물 2

HCID 8895Cupric acetate

HCID 93164N-Decylimidazole

실험 절차

104 parts of 1-decylimidazole and 100 parts of copper(II) acetate monohydrate are intimately mixed at 140° C. After cooling, there is obtained 195 parts of a pale blue, pasty mass of a complex of 1-decylimidazole and copper acetate (active ingredient 66).

후처리

temperatureAfter cooling

출처 및 근거

ORD 기록: ord-b1c5037326714151a788834d883344fb
출처 데이터셋: uspto-grants-1982_07
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US04339448

반응 노트

불러오는 중…